2022-11-29 |
2022-11-28 |
S
Sale
|
CAPPS VICKIE L
Non-Executive Director
|
42,242
-92.6%
0.10
4,342
USD
|
42,242
-92.6%
|
0.10
|
4,342
USD
|
|
2022-03-29 |
2022-03-28 |
S
Sale
|
Foster Alan Charles
Chief Scientific Officer
Officer
|
2,559
-1.4%
2.41
6,175
USD
|
2,559
-1.4%
|
2.41
|
6,175
USD
|
|
2022-03-29 |
2022-03-28 |
S
Sale
|
Cayer Paul E
Ch. Financial & Business Offcr
Officer
|
5,624
-2.5%
2.41
13,571
USD
|
5,624
-2.5%
|
2.41
|
13,571
USD
|
|
2022-03-29 |
2022-03-28 |
S
Sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
3,325
-2.2%
2.41
8,023
USD
|
3,325
-2.2%
|
2.41
|
8,023
USD
|
|
2022-03-29 |
2022-03-28 |
S
Sale
|
Weber David Allen
President & CEO
Executive Director
|
11,243
-2.9%
2.41
27,129
USD
|
11,243
-2.9%
|
2.41
|
27,129
USD
|
|
2022-03-29 |
2022-03-25 |
S
Sale
|
Foster Alan Charles
Chief Scientific Officer
Officer
|
1,827
-1.0%
2.39
4,363
USD
|
1,827
-1.0%
|
2.39
|
4,363
USD
|
|
2022-03-29 |
2022-03-25 |
S
Sale
|
Cayer Paul E
Ch. Financial & Business Offcr
Officer
|
4,015
-1.7%
2.39
9,588
USD
|
4,015
-1.7%
|
2.39
|
9,588
USD
|
|
2022-03-29 |
2022-03-25 |
S
Sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
2,374
-1.6%
2.39
5,669
USD
|
2,374
-1.6%
|
2.39
|
5,669
USD
|
|
2022-03-29 |
2022-03-25 |
S
Sale
|
Weber David Allen
President & CEO
Executive Director
|
8,026
-2.0%
2.39
19,166
USD
|
8,026
-2.0%
|
2.39
|
19,166
USD
|
|
2021-03-03 |
2021-03-03 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
113,935
-100.0%
2.70
307,397
USD
|
113,935
-100.0%
|
2.70
|
307,397
USD
|
|
2021-03-03 |
2021-03-03 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
207,245
-100.0%
2.70
559,147
USD
|
207,245
-100.0%
|
2.70
|
559,147
USD
|
|
2021-03-02 |
2021-03-02 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
138,199
-54.8%
2.90
400,639
USD
|
138,199
-54.8%
|
2.90
|
400,639
USD
|
|
2021-03-02 |
2021-03-02 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
251,375
-54.8%
2.90
728,736
USD
|
251,375
-54.8%
|
2.90
|
728,736
USD
|
|
2021-03-02 |
2021-03-01 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
61,619
-19.6%
2.86
175,984
USD
|
61,619
-19.6%
|
2.86
|
175,984
USD
|
|
2021-03-02 |
2021-03-01 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
112,081
-19.6%
2.86
320,103
USD
|
112,081
-19.6%
|
2.86
|
320,103
USD
|
|
2021-03-02 |
2021-02-26 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
117,262
-27.2%
2.83
331,851
USD
|
117,262
-27.2%
|
2.83
|
331,851
USD
|
|
2021-03-02 |
2021-02-26 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
213,292
-27.2%
2.83
603,616
USD
|
213,292
-27.2%
|
2.83
|
603,616
USD
|
|
2021-02-25 |
2021-02-25 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
110,361
-20.4%
2.95
326,006
USD
|
110,361
-20.4%
|
2.95
|
326,006
USD
|
|
2021-02-25 |
2021-02-25 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
200,739
-20.4%
2.95
592,983
USD
|
200,739
-20.4%
|
2.95
|
592,983
USD
|
|
2021-02-25 |
2021-02-24 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
178,484
-24.8%
2.98
532,239
USD
|
178,484
-24.8%
|
2.98
|
532,239
USD
|
|
2021-02-25 |
2021-02-24 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
324,651
-24.8%
2.98
968,109
USD
|
324,651
-24.8%
|
2.98
|
968,109
USD
|
|
2021-02-25 |
2021-02-23 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
95,113
-11.7%
2.89
274,686
USD
|
95,113
-11.7%
|
2.89
|
274,686
USD
|
|
2021-02-25 |
2021-02-23 |
S
Sale
|
Lichter Jay
Non-Executive Director
|
173,005
-11.7%
2.89
499,638
USD
|
173,005
-11.7%
|
2.89
|
499,638
USD
|
|
2017-06-27 |
2017-06-26 |
PS
Planned sale
|
LOUMEAU ERIC J
GC & Chief Compliance Officer
|
1,206
-100.0%
18.75
22,613
USD
|
1,206
-100.0%
|
18.75
|
22,613
USD
|
|
2017-06-27 |
2017-06-23 |
PS
Planned sale
|
LOUMEAU ERIC J
GC & Chief Compliance Officer
|
2,316
-65.8%
18.50
42,846
USD
|
2,316
-65.8%
|
18.50
|
42,846
USD
|
|
2016-11-22 |
2016-11-21 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
1,456
-13.3%
18.07
26,303
USD
|
1,456
-13.3%
|
18.07
|
26,303
USD
|
|
2016-11-22 |
2016-11-18 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
9,169
-49.2%
18.07
165,703
USD
|
9,169
-49.2%
|
18.07
|
165,703
USD
|
|
2016-09-08 |
2016-09-06 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
5,304
-35.9%
17.95
95,207
USD
|
5,304
-35.9%
|
17.95
|
95,207
USD
|
|
2016-09-08 |
2016-09-06 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
3,813
-20.5%
17.95
68,443
USD
|
3,813
-20.5%
|
17.95
|
68,443
USD
|
|
2016-09-08 |
2016-09-06 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
12,133
-39.5%
17.95
217,787
USD
|
12,133
-39.5%
|
17.95
|
217,787
USD
|
|
2015-12-22 |
2015-12-21 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
8,061
-47.5%
28.38
228,753
USD
|
8,061
-47.5%
|
28.38
|
228,753
USD
|
|
2015-12-22 |
2015-12-21 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
13,189
-43.7%
27.83
367,074
USD
|
13,189
-43.7%
|
27.83
|
367,074
USD
|
|
2015-12-18 |
2015-12-17 |
PS
Planned sale
|
Cayer Paul E
Ch. Financial & Business Offcr
Officer
|
300
-3.0%
30.19
9,056
USD
|
300
-3.0%
|
30.19
|
9,056
USD
|
|
2015-12-18 |
2015-12-17 |
PS
Planned sale
|
Cayer Paul E
Ch. Financial & Business Offcr
Officer
|
2,700
-21.4%
29.65
80,045
USD
|
2,700
-21.4%
|
29.65
|
80,045
USD
|
|
2015-12-16 |
2015-12-15 |
PS
Planned sale
|
Weber David Allen
President & CEO
Executive Director
|
5,208
-22.8%
27.25
141,917
USD
|
5,208
-22.8%
|
27.25
|
141,917
USD
|
|
2015-12-16 |
2015-12-14 |
S
Sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
100
-7.4%
27.70
2,770
USD
|
100
-7.4%
|
27.70
|
2,770
USD
|
|
2015-12-16 |
2015-12-14 |
S
Sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
1,289
-48.7%
27.26
35,136
USD
|
1,289
-48.7%
|
27.26
|
35,136
USD
|
|
2015-12-16 |
2015-12-14 |
S
Sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
1,289
-32.8%
26.15
33,706
USD
|
1,289
-32.8%
|
26.15
|
33,706
USD
|
|
2015-12-16 |
2015-12-14 |
PS
Planned sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
2,322
-37.1%
25.14
58,363
USD
|
2,322
-37.1%
|
25.14
|
58,363
USD
|
|
2015-11-30 |
2015-11-30 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
590
-0.0%
29.22
17,240
USD
|
590
-0.0%
|
29.22
|
17,240
USD
|
|
2015-11-30 |
2015-11-30 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
2,716
-0.1%
28.64
77,786
USD
|
2,716
-0.1%
|
28.64
|
77,786
USD
|
|
2015-11-30 |
2015-11-30 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
590
-0.0%
29.22
17,240
USD
|
590
-0.0%
|
29.22
|
17,240
USD
|
|
2015-11-30 |
2015-11-30 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
2,716
-0.1%
28.64
77,786
USD
|
2,716
-0.1%
|
28.64
|
77,786
USD
|
|
2015-11-30 |
2015-11-27 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
29,000
-1.5%
28.97
840,130
USD
|
29,000
-1.5%
|
28.97
|
840,130
USD
|
|
2015-11-30 |
2015-11-27 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
29,000
-1.5%
28.97
840,130
USD
|
29,000
-1.5%
|
28.97
|
840,130
USD
|
|
2015-11-30 |
2015-11-25 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
34,800
-1.8%
28.91
1,006,068
USD
|
34,800
-1.8%
|
28.91
|
1,006,068
USD
|
|
2015-11-30 |
2015-11-25 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
34,800
-1.8%
28.91
1,006,068
USD
|
34,800
-1.8%
|
28.91
|
1,006,068
USD
|
|
2015-11-24 |
2015-11-24 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
36,100
-1.8%
28.75
1,037,875
USD
|
36,100
-1.8%
|
28.75
|
1,037,875
USD
|
|
2015-11-24 |
2015-11-24 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
36,100
-1.8%
28.75
1,037,875
USD
|
36,100
-1.8%
|
28.75
|
1,037,875
USD
|
|
2015-11-24 |
2015-11-23 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
80,800
-4.0%
28.45
2,298,760
USD
|
80,800
-4.0%
|
28.45
|
2,298,760
USD
|
|
2015-11-24 |
2015-11-23 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
80,800
-4.0%
28.45
2,298,760
USD
|
80,800
-4.0%
|
28.45
|
2,298,760
USD
|
|
2015-11-24 |
2015-11-20 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
83,900
-4.0%
28.59
2,398,701
USD
|
83,900
-4.0%
|
28.59
|
2,398,701
USD
|
|
2015-11-24 |
2015-11-20 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
83,900
-4.0%
28.59
2,398,701
USD
|
83,900
-4.0%
|
28.59
|
2,398,701
USD
|
|
2015-11-19 |
2015-11-19 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
127,300
-5.7%
28.60
3,640,780
USD
|
127,300
-5.7%
|
28.60
|
3,640,780
USD
|
|
2015-11-19 |
2015-11-19 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
127,300
-5.7%
28.60
3,640,780
USD
|
127,300
-5.7%
|
28.60
|
3,640,780
USD
|
|
2015-11-19 |
2015-11-17 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
200
-0.0%
29.09
5,818
USD
|
200
-0.0%
|
29.09
|
5,818
USD
|
|
2015-11-19 |
2015-11-17 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
200
-0.0%
29.09
5,818
USD
|
200
-0.0%
|
29.09
|
5,818
USD
|
|
2015-11-19 |
2015-11-17 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
10,898
-0.5%
28.80
313,862
USD
|
10,898
-0.5%
|
28.80
|
313,862
USD
|
|
2015-11-19 |
2015-11-17 |
S
Sale
|
Khuong Chau Quang
Non-Executive Director
|
10,898
-0.5%
28.80
313,862
USD
|
10,898
-0.5%
|
28.80
|
313,862
USD
|
|
2015-11-17 |
2015-11-17 |
PS
Planned sale
|
Cayer Paul E
Ch. Financial & Business Offcr
Officer
|
3,000
-23.8%
28.69
86,057
USD
|
3,000
-23.8%
|
28.69
|
86,057
USD
|
|
2015-11-17 |
2015-11-16 |
S
Sale
|
Weber David Allen
President & CEO
Executive Director
|
100
-0.6%
29.25
2,925
USD
|
100
-0.6%
|
29.25
|
2,925
USD
|
|
2015-11-17 |
2015-11-16 |
PS
Planned sale
|
Weber David Allen
President & CEO
Executive Director
|
5,108
-22.4%
28.56
145,887
USD
|
5,108
-22.4%
|
28.56
|
145,887
USD
|
|
2015-11-13 |
2015-11-13 |
PS
Planned sale
|
Weber David Allen
President & CEO
Executive Director
|
10,416
-95.1%
30.95
322,375
USD
|
10,416
-95.1%
|
30.95
|
322,375
USD
|
|
2015-11-12 |
2015-11-11 |
PS
Planned sale
|
Cayer Paul E
CFO/Ch. Business Offcr & Sec.
Officer
|
3,000
-23.8%
24.95
74,850
USD
|
3,000
-23.8%
|
24.95
|
74,850
USD
|
|
2015-11-12 |
2015-11-11 |
PS
Planned sale
|
Weber David Allen
President & CEO
Executive Director
|
5,208
-90.6%
24.95
129,940
USD
|
5,208
-90.6%
|
24.95
|
129,940
USD
|
|
2015-09-22 |
2015-09-21 |
PS
Planned sale
|
LeBel Carl
Chief Scientific Officer
Officer
|
21,250
-70.4%
24.36
517,576
USD
|
21,250
-70.4%
|
24.36
|
517,576
USD
|
|
2015-09-18 |
2015-09-17 |
PS
Planned sale
|
Cayer Paul E
CFO/Ch. Business Offcr & Sec.
Officer
|
3,000
-23.8%
24.95
74,850
USD
|
3,000
-23.8%
|
24.95
|
74,850
USD
|
|
2015-09-16 |
2015-09-15 |
PS
Planned sale
|
Weber David Allen
President & CEO
Executive Director
|
5,216
-90.6%
24.95
130,139
USD
|
5,216
-90.6%
|
24.95
|
130,139
USD
|
|
2015-09-15 |
2015-09-14 |
PS
Planned sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
5,000
-79.9%
23.98
119,897
USD
|
5,000
-79.9%
|
23.98
|
119,897
USD
|
|
2015-06-17 |
2015-06-15 |
PS
Planned sale
|
Savel Robert Michael II
Chief Technical Officer
Officer
|
25,000
-95.2%
23.73
593,285
USD
|
25,000
-95.2%
|
23.73
|
593,285
USD
|
|
2015-05-27 |
2015-05-22 |
B
Purchase
|
CAPPS VICKIE L
Non-Executive Director
|
1,600
+inf%
24.35
38,960
USD
|
1,600
+inf%
|
24.35
|
38,960
USD
|
|
2015-05-27 |
2015-05-22 |
B
Purchase
|
CAPPS VICKIE L
Non-Executive Director
|
3,400
+inf%
24.36
82,808
USD
|
3,400
+inf%
|
24.36
|
82,808
USD
|
|
2014-08-21 |
2014-08-19 |
B
Purchase
|
Novo A/S
SEE REMARKS
Major owner
|
15,690
+0.7%
15.50
243,135
USD
|
15,690
+0.7%
|
15.50
|
243,135
USD
|
|
2014-08-19 |
2014-08-18 |
B
Purchase
|
Novo A/S
SEE REMARKS
Major owner
|
171,875
+8.6%
16.00
2,750,000
USD
|
171,875
+8.6%
|
16.00
|
2,750,000
USD
|
|
2014-08-19 |
2014-08-18 |
B
Purchase
|
Avalon Ventures VIII LP
Major owner
|
109,375
+15.5%
16.00
1,750,000
USD
|
109,375
+15.5%
|
16.00
|
1,750,000
USD
|
|